enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
BOSTON & MONTREAL — enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced that it will host a conference call and webcast tomorrow, November 11, 2025, at 8:00 a.m. ET to discus
(Financial Post, 2025-11-10T21:10:08Z)